Assessment of Response to Thienopyridine in Japanese Population (ART-JP)

Not Applicable

Completed

• Conditions: coronary artery disease (CAD)

• Registration Number: JPRN-UMIN000006336
• Lead Sponsor: Keio University, School of Medicine, Research Park 5S9

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09-13
• Study Completion: 2014-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

1) patients without consent 2) AST > or = 3 x upper limit or ALT > or = 3 x upper 3) Hb < 10 g/dl or platelet < 100k 4) drug allergy to thienopyridine 5) patients with malignancy under treatment or planning to start treatment within one year 6) primary physician thinks it is inappropriate to enroll the patient

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
cardiac death, fatal stroke, non-fatal myocardial infarction, stent thrombosis

Secondary Outcome Measures

Name	Time	Method
repeat PCI, non cardiovasular death, non-fatal stroke, non-fatal cerebral hemorrhage, bleeding (STEEPLE major or minor), change in bio-marker